Labshake search
Citations for R&D Systems :
601 - 650 of 1380 citations for GABARAPL2 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Physiology 2023Quote: ... Cells were stimulated by addition of recombinant human IL-1β (R&D Systems) and/or filter-concentrated JAR cell conditioned media as indicated ...
-
bioRxiv - Microbiology 2023Quote: ... 2) 50 nM recombinant USP2 catalytic domain (R&D systems, Cat# E-504), 3 ...
-
bioRxiv - Bioengineering 2023Quote: ... or 1000 ng/mL of recombinant human IFN-γ (R&D Systems, 285IF100) and TNF-α (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... 50 μg/mL TrkB-Fc (Recombinant Human Chimera, 688-TK, R&D Systems) was injected intraventricularly ...
-
bioRxiv - Developmental Biology 2023Quote: ... 100 ng/mL recombinant CXCL12/SDF-1 (350-NS/CF; R&D Systems) was added to the medium ...
-
bioRxiv - Immunology 2023Quote: ... MEFs were stimulated with 500 U/ml recombinant IFN-β (R&D Systems) for the indicated times ...
-
bioRxiv - Cancer Biology 2022Quote: ... recombinant human SHH (high activity (R&D Systems: Cat # 8908-SH-005/CF), and fixed after indicated treatment durations and processed as described below ...
-
bioRxiv - Systems Biology 2023Quote: ... BTC at 40 ng/mL (human recombinant Betacellulin protein, R&D systems, MN), or combinations of all for 6 hours ...
-
Lysyl oxidase regulates epithelial differentiation and barrier integrity in eosinophilic esophagitisbioRxiv - Cell Biology 2023Quote: ... 10 ng/ml recombinant BMP2 protein (R&D Systems, Inc., Minneapolis, MN, USA), or vehicle (phosphate-buffered saline for IL-13 and hydrochloride for BMP2 ...
-
bioRxiv - Physiology 2023Quote: ... Activity of BCAT was assessed using recombinant human BCAT2 (rhBCAT2; R&D Systems)41 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were then stimulated with recombinant TGFβ2 (10 ng/mL, R&D Systems), recombinant CXCL4 (5 µg/mL ...
-
bioRxiv - Bioengineering 2023Quote: ... and recombinant human interleukin-4 (IL-4) (50 ng/mL) (R&D systems).
-
bioRxiv - Cancer Biology 2023Quote: ... Serum-deprived media ±recombinant human CCL8 or CCL15 (R&D Systems, Minnneapolis, MN) and ±5 μg/ml neutralizing antibodies for CCR1 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and recombinant human TIM-4-HIS (R&D Systems, Cat# 9407-TM-050)) ...
-
bioRxiv - Pathology 2023Quote: ... were treated with recombinant human osteopontin (rhOPN; R&D Systems, 1433-OP-050) for 24 hours in serum and supplement-free growth medium (EGM ...
-
bioRxiv - Cancer Biology 2023Quote: ... recombinant E-selectin– human-IgG1 fusion protein (724 ES 100, R&D Systems) was pre-complexed at 5µg/mL with PE-conjugated goat anti-Human IgG diluted at 1/100e (Supplementary Table 2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... Then the beads were incubated with purified recombinant LG3BP (source R&D Systems) and washed thrice with IP buffer ...
-
bioRxiv - Cancer Biology 2023Quote: ... Recombinant human galectin 3 binding protein (R&D Systems, and produced in-house), QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) ...
-
bioRxiv - Neuroscience 2023Quote: Brain slices were treated with 150 ng/ml recombinant DKK3 (R&D systems) or vehicle control (PBS ...
-
bioRxiv - Cell Biology 2023Quote: ... 50 ng/ml recombinant human Wnt3a (R&D Systems; day 1 and 2), 1 mM L-Glutamine (L-Glu ...
-
bioRxiv - Immunology 2024Quote: ... with 100 ng of recombinant murine IL-1β (R&D Systems, Minneapolis, MN). At start of the experiment ...
-
bioRxiv - Cancer Biology 2024Quote: ... Recombinant Human Interferon alpha 2a (IFN-alpha) was purchased from R&D systems. Cisplatin was purchased from Sigma-Aldrich.
-
bioRxiv - Pathology 2019Quote: ... and then stained with 15 μl mouse PE-conjugated F4/80 mAbs (Cat#: FAB5580P-100UG, R&D system), and co-incubated with 30 μl anti-PE magnetic beads for 20 min ...
-
bioRxiv - Immunology 2020Quote: ... The cells were then stained with directly-conjugated LILRB3 mAb (clone 222821; mouse IgG2a; R&D Systems, UK) for 20 minutes at 4°C ...
-
bioRxiv - Biochemistry 2022Quote: ... then incubated with 1:1000 α-polySia mAb 735 (BioAspect) or 1:2000 α-NCAM (R&D Systems) in blocking buffer at room temperature overnight ...
-
bioRxiv - Immunology 2023Quote: ... Using a SARS-CoV-2 spike RBD mAb of known concentration (MAB10580; R&D Systems, Minneapolis, Minnesota, USA) as a molecular standard ...
-
bioRxiv - Biochemistry 2021Quote: ... 16055 NFL trimers were captured on the ELISA plate by a mouse anti-His tag mAb (R&D Systems) coated at 2 μg/ml in PBS at 4°C overnight ...
-
bioRxiv - Biophysics 2019Quote: ... and the anti-CCR5 mAb (Clone 2D7) directly coupled to phycoerythrin (PE) was from R&D Systems (Minneapolis, MN), anti-CCR5 (Clone T21/8 ...
-
bioRxiv - Cancer Biology 2021Quote: ... the cells were treated with recombinant human IFNγ (R&D Systems, 285-IF-100) by adding an equal volume of the complete culture media containing the cytokine ...
-
bioRxiv - Neuroscience 2020Quote: ... and human recombinant FGF2 (10 ng/ml, R&D Systems, Minneapolis, Minnesota; 233-FB). After two to three weeks ...
-
bioRxiv - Cell Biology 2019Quote: ... Recombinant human TGF-β (7754-BH) was purchased from R&D Systems (Minneapolis, MI). It was reconstituted at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% BSA ...
-
bioRxiv - Cell Biology 2020Quote: ... during 2 hours and stimulated with human recombinant VEGF165 (25ng/ml, R&D System) during 30 minutes.
-
bioRxiv - Genomics 2019Quote: ... 50 ng/mL carrier-free recombinant human stem cell factor (SCF; R&D Systems), 50 ng/mL TPO (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... cells were treated with 100ng/mL human recombinant FGF4 (R&D Systems, 235-F4) in the presence of 10 μg/mL heparin sulfate and 3 μM BI-D1870 RSK inhibitor at 37°C ...
-
bioRxiv - Neuroscience 2021Quote: ... where the medium was supplemented with recombinant Netrin (100 ng/ml, R&D Systems).
-
bioRxiv - Neuroscience 2020Quote: ... NMPM: N2B27 supplemented with 40 ng/ml recombinant human (rh) FGF2 (R&D Systems), 40 ng/ml rhFGF8 (R&D Systems) ...
-
bioRxiv - Developmental Biology 2019Quote: ... 0.1% of recombinant mouse Oncostatin M 10μg/ml (R&D Systems, #495-MO-025); 0.01% of recombinant human FGF basic protein 10μg/ml (R&D Systems ...
-
bioRxiv - Cell Biology 2020Quote: ... were incubated with 100μg/ml recombinant human Wnt10b protein (0.1mg/ml;R&D Systems) at 37°C for 30 minutes ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant pro-legumain (asparaginyl endopeptidase) was purchased from R&D Systems (2199-CY), activated per manufacturer instruction and active site titrated using MP-L01 inhibitor as described by Poreba et al ...
-
bioRxiv - Bioengineering 2019Quote: ... 0.004 % of recombinant human FGF basic (FGF-2, R&D Systems, Abingdon, United Kingdom) was added ...
-
bioRxiv - Neuroscience 2019Quote: Recombinant human IDO (Accession #P14902) was obtained from R&D Systems (#6030-AO-010) and frozen at −80°C until use ...
-
bioRxiv - Cancer Biology 2019Quote: ... Recombinant human TGFβ-1 (cat# 240B002) was purchased from R&D systems (Minneapolis, MN). Alexa 488-conjugated phalloidin (cat# A12379 ...
-
bioRxiv - Immunology 2021Quote: ... recombinant human IL-4 at 50 ng/ml (R&D Systems, Minneapolis, MN, USA) for 6 h ...
-
bioRxiv - Bioengineering 2020Quote: ... and 2.5 ng mL−1 recombinant mouse FGF2 (R&D Systems # 3139-FB-025). In some experiments ...
-
bioRxiv - Bioengineering 2020Quote: ... and recombinant human IL-2 (50 U/mL, R&D Systems, Minneapolis, MN, USA). Single cell suspensions were activated with 1 μg/ml Concavalin A (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... From day 10 the medium was supplemented with 3nM recombinant SHH (R&D Systems), 50ng/μl acidic fibroblast growth factor (αFGF ...
-
bioRxiv - Cancer Biology 2021Quote: ... Luciferase activity was confirmed using recombinant human TGFβ (R&D Systems, #240-B-010) treatment.
-
bioRxiv - Pharmacology and Toxicology 2020Quote: Recombinant human FGF23 and FGF2 were purchased from R&D Systems (Minneapolis, MN, USA). Synthetic human C-terminal FGF23 (residues 180-251 ...
-
bioRxiv - Bioengineering 2021Quote: ... 100M PBMCs were thawed in 100 mL X-VIVO™ 10 media from Lonza (#04-380Q) with recombinant human IL-2 protein from R&D Systems (#202-IL). After a 24 hr culture out of thaw the PBMCs were activated with ImmunoCult™ human CD3/CD28 T cell activator reagent from STEMCELL Technologies (#10971 ...
-
bioRxiv - Cancer Biology 2020Quote: Murine recombinant FGF2 and IL-1β were acquired from R&D Systems (Minneapolis, MN). The proteinase K and Benzonase were purchased from Sigma-Aldrich ...